Christopher Griffith - Dermira Insider

Dermira Inc -- USA Stock  

USD 9.10  0.16  1.79%

Co-Founder and VP of Corporate Devel. and Strategy

Mr. Christopher M. Griffith is Senior Vice President Corporationrationrate Development and Strategy, Founder of the Company. He founded our company in August 2010 and has served as our Senior Vice President of Corporationrationrate Development and Strategy since January 2017, after previously serving as our Vice President of Corporationrationrate Development and Strategy since August 2011 and Head of Corporationrationrate Development and Strategy since September 2010. From July 2005 to September 2010, Mr. Griffith worked in corporate development at Gilead Sciences, Inc., most recently as Associate Director of Corporationrationrate Development. From May 2004 to August 2004, Mr. Griffith worked in the biooncology strategy group at Genentech, Inc., a biotechnology company. From 2001 to 2003, Mr. Griffith worked at Bay City Capital
Age: 39  Founder Since 2017  MBA    
Griffith received B.S. and M.S. degrees in biological sciences from Stanford University and an M.B.A. degree from Harvard Business School.

Christopher Griffith Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (24.58) % which means that it has lost $24.58 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (152.77) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 279.39 M in liabilities with Debt to Equity (D/E) ratio of 186.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Dermira Inc has Current Ratio of 5.17 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

Dermira, Inc., a biopharmaceutical company, identifies, develops, and commercializes therapies to treat dermatologic diseases. Dermira, Inc. was founded in 2010 and is headquartered in Menlo Park, California. Dermira operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 162 people.Dermira Inc (DERM) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 162 people. Dermira is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Transaction History Now

Transaction History

View history of all your transactions and understand their impact on performance
Hide  View All  NextLaunch Transaction History
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Dermira Inc to your portfolio

Top Management

Dermira Inc Leadership Team
Jake Nunn, Director, CFA
Frederick Craves, Director
William Young, Chairman
Lori LyonsWilliams, Executive, MBA
Christopher Griffith, Founder, MBA
Matthew Fust, Director, MBA
David Cohen, Director, Ph.D
Kathleen Sebelius, Director
Mark McDade, Director, MBA
Emmanuel Caeymaex, Director
William Ringo, Director, MBA
Luis Pena, Founder
Thomas Wiggans, Chairman, MBA
Eugene Bauer, Director
Andrew Guggenhime, COO, MBA

Stock Performance

Dermira Performance Indicators